Advertisement

Environmental Pathology

  • José A. Centeno
  • Florabel G. Mullick
  • Kamal G. Ishak
  • Teri J. Franks
  • Allen P. Burke
  • Michael N. Koss
  • Daniel P. Perl
  • Paul B. Tchounwou
  • Joseph P. Pestaner
Chapter

Abstract

Humans are constantly exposed to hazardous pollutants in the environment—for example, in the air, water, soil, rocks, diet, or workplace. Trace metals are important in environmental pathology because of the wide range of toxic reactions and their potential adverse effects on the physiological function of organ systems. Exposures to toxic trace metals have been the subject of numerous environmental and geochemical investigations, and many studies have been published on the acute and/or chronic effects of high-level exposures to these types of agents; however, much fewer data are available concerning the health effects of low-dose chronic exposure to many trace metals. Chronic low-dose exposures to toxic elements such as cadmium and arsenic have been shown to cause these metals to accumulate in tissues over time, leading to multiple adverse effects in exposed individuals.

Keywords

Dilate Cardiomyopathy Iron Overload Lead Exposure Asbestos Exposure Selenium Deficiency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

The authors would like to express their appreciation to Drs. Elena Ladich, Todor Todorov, Leonor Martinez, Elizabeth Meze, and Linda Murakata for their valuable contributions during the preparation of this chapter.

Further Reading

  1. Adams PC, Bradley C, Frei JV (1994) Hepatic iron and zinc concentrations after portacaval shunting for nonalcoholic cirrhosis. Hepatology 19:101–105CrossRefGoogle Scholar
  2. American Thoracic Society (1986) The diagnosis of nonmalignant diseases related to asbestos. Am Rev Respir Dis 134:363–368Google Scholar
  3. Andrews N (1999) Disorders of iron metabolism. N Engl J Med 341:1886–1995CrossRefGoogle Scholar
  4. Barchowsky A, Dudek EJ, Treadwell MD, Wetterhahn KE (1996) Arsenic induces oxidant stress and NFKB activation in cultured aortic endothelial cells. Free Radic Biol Med 21:783–790CrossRefGoogle Scholar
  5. Barnhart S, Thornquist M, Omenn G et al (1990) The degree of roentgenographic parenchymal opacities attributable to smoking among asbestos-exposed subjects. Am Rev Respir Dis 141:1102–1106Google Scholar
  6. Barrett JC, Lamb PW, Wang TC, Lee TC (1989) Mechanisms of arsenic-induced cell transformation. Biol Trace Elem Res 21:421–429CrossRefGoogle Scholar
  7. Barry M, Scheuer PJ, Sherlock S et al (1968) Hereditary spherocytosis with secondary haemochromatosis. Lancet 2:481–485CrossRefGoogle Scholar
  8. Barton AL, Banner BF, Cable EE et al (1995a) Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy. Am J Clin Pathol 103:419–424Google Scholar
  9. Barton JC, Edwards CQ, Bertoli LF et al (1995b) Iron overload in African Americans. Am J Med 99:616–623CrossRefGoogle Scholar
  10. Becklake M (1983) Occupational lung disease: past record and future trend using the asbestos case as an example. Clin Invest Med 6:305–337Google Scholar
  11. Belton JC, Benson NC, Hanna ML, Taylor RT (1985) Growth inhibition and cytotoxic effects of three arsenic compounds on cultured Chinese hamster ovary cells. J Environ Sci Health 20A:37–72Google Scholar
  12. Bhagwat AG, Walia BN, Koshy A, Banerji CK (1983) Will the real Indian childhood cirrhosis please stand up? Cleve Clin Q 50:323–337Google Scholar
  13. Bhusnurmath SR, Walia BNS, Singh S et al (1991) Sequential histopathologic alterations in Indian childhood cirrhosis treated with D-penicillamine. Hum Pathol 22:653–658CrossRefGoogle Scholar
  14. Blomfield J, Dixon SR, McCredie DA (1971) Potential hepatotoxicity of copper in recurrent hemodialysis. Arch Intern Med 128:555–560CrossRefGoogle Scholar
  15. Boffetta P, Sallsten G, Garcia-Gomez M, Pompe-Kirn V, Zaridze D, Bulbulyan M, Caballero JD, Ceccarelli F, Kobal AB, Merler E (2001) Mortality from cardiovascular diseases and exposure to inorganic mercury. Occup Environ Med 58:461–466CrossRefGoogle Scholar
  16. Bonkovsky HL, Lambrecht RW (2000) Iron-induced liver injury. Clin Liver Dis 4:409–429CrossRefGoogle Scholar
  17. Bonkovsky HL, Banner BF, Lambrecht RW, Rubin RB (1996) Iron in diseases other than hemochromatosis. Semin Liver Dis 16:65–82CrossRefGoogle Scholar
  18. Bonkovsky HL, Jawaid Q, Tortorelli K et al (1999) Non-alcoholic steatohepatitis and iron; increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol 31:421–429CrossRefGoogle Scholar
  19. Brain J, Valberg P (1979) Deposition of aerosol in the respiratory tract. Am Rev Respir Dis 120:1325–1373Google Scholar
  20. Brenard R, Laterre PF, Reynaert M et al (1996) Increased hepatocytic mitotic activity as a diagnostic marker of acute arsenic intoxication. J Hepatol 25:218–220CrossRefGoogle Scholar
  21. Browne K (1986) A threshold for asbestos related lung cancer. Br J Ind Med 43:556–558Google Scholar
  22. Browne K (1994) Asbestos-related disorders. In: Parkes W (ed) Occupational lung disorders. Butterworth-Heinemann, OxfordGoogle Scholar
  23. Cavanagh JB, Nolan CC (1994) The neurotoxicity of organolead and organotin compounds. In: de Wolff FA (ed) Handbook of clinical neurology, vol 20. Elsevier, Amsterdam, pp 129–150Google Scholar
  24. Cavigelli M, Li WW, Lin A, Su B, Yushioka K, Karin M (1996) The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBO J 15:6269–6279Google Scholar
  25. Centeno JA, Pestaner JP, Mullick FG, Virmani R (1996) An analytical comparison of cobalt cardiomyopathy and idiopathic dilated cardiomyopathy. Biol Trace Elem Res 55:21–30CrossRefGoogle Scholar
  26. Chan P, Huff J (1997) Arsenic carcinogenesis in animals and in humans: mechanistic, experimental, and epidemiological evidence. Environ Carcinog Ecotoxicol Rev 15:83–122Google Scholar
  27. Chen CJ, Chen CW, Wu MM, Kuo TL (1992) Cancer potential in liver, lung, bladder, and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer 66:888–892CrossRefGoogle Scholar
  28. Choie DD, Richter GW (1972) Lead poisoning: rapid formation of intranuclear inclusions. Science 177(55):1194–1195CrossRefGoogle Scholar
  29. Chou HT, Yang HL, Tsou SS, Ho RK, Pai PY, Hsu HB (1998) Status of trace elements in patients with idiopathic dilated cardiomyopathy in central Taiwan. Chung Hua I Hsueh Tsa Chih (Taipei) 61:193–198Google Scholar
  30. Chung C, Tsai R, Chen G, Yu H, Chai C (1998) Expression of bcl-2, p53 and Ki-67 in arsenical skin cancers. J Cutan Pathol 25:457–462CrossRefGoogle Scholar
  31. Churg A (1998a) Non-neoplastic disease caused by asbestos. In: Churg A, Green F (eds) Pathology of occupational lung disease. Williams & Wilkins, BaltimoreGoogle Scholar
  32. Churg A (1998b) Neoplastic asbestos-induced disease. In: Churg A, Green F (eds) Pathology of occupational lung disease. Williams & Wilkins, BaltimoreGoogle Scholar
  33. Churg A, Colby T (1998) Diseases caused by metals and related compounds. In: Churg A, Green F (eds) Pathology of occupational lung disease. Williams & Wilkins, BaltimoreGoogle Scholar
  34. Churg A, Warnock M (1981) Asbestos and other ferruginous bodies. Am J Pathol 102:447–456Google Scholar
  35. Churg A, Wright J, Vedal S (1993) Fiber burden and patterns of asbestos-related disease in chrysotile miners and millers. Am Rev Respir Dis 148:25–31Google Scholar
  36. Chuttani HK, Gupta PS, Gulati S, Gupta DN (1965) Acute copper sulfate poisoning. Am J Med 39:849–854CrossRefGoogle Scholar
  37. Craighead J, Abraham J, Churg A et al (1982) The pathology of asbestos-associated diseases of the lungs and pleural cavities: diagnostic criteria and proposed grading schema (report of the pneumoconiosis committee of the college of American pathologists and the national institute for occupational safety and health). Arch Pathol Lab Med 106:544–596Google Scholar
  38. Datta DV, Mitra SK, Chhuttani PN, Chakravarti RN (1979) Chronic oral arsenic intoxication as a possible aetiological factor in idiopathic portal hypertension (non-cirrhotic portal fibrosis) in India. Gut 20:378–384CrossRefGoogle Scholar
  39. de Valk B, Marx JJ (1999) Iron, atherosclerosis, and ischemic heart disease. Arch Intern Med 159:1542–1548CrossRefGoogle Scholar
  40. Denk R, Holzmann H, Lange HJ, Greve D (1959) Uber Arsenspatschaden bei obduzierten Moselwinzern. Med Welt 11:557–567Google Scholar
  41. Deugnier Y, Turlin B, Le Quilleue D et al (1997) A reappraisal of hepatic siderosis in patients with end-stage cirrhosis: practical implications for the diagnosis of hemochromatosis. Am J Surg Pathol 21:669–675CrossRefGoogle Scholar
  42. 1999 Diseases of immunity. In: Cotran R, Kumar V, Collins T (eds) Pathologic basis of disease. W. B. Saunders, Philadelphia, pp 188–259Google Scholar
  43. Doll R (1993) Mortality from lung cancer in asbestos workers 1955 (classical article). Br J Ind Med 50:485–490Google Scholar
  44. Dupres J, Mustard J, Uffen R (1984) Report of the royal commission on matters of health and safety arising from the use of asbestos in Ontario. Queen’s Printer for Ontario, TorontoGoogle Scholar
  45. Elis A, Froom P, Ninio A, Cahana L, Lishner M (2001) Employee exposure to chromium and plasma lipid oxidation. Int J Occup Environ Health 7:206–208Google Scholar
  46. Elzouki A-NY, Hulterantz R, Stäl P et al (1995) Increased PiZ frequency for α-1 antitrypsin in patients with genetic hemochromatosis. Gut 36:922–926CrossRefGoogle Scholar
  47. Epler G, McLoud T, Gaensler E (1982) Prevalence and incidence of benign asbestos pleural effusion in a working population. JAMA 247:617–622CrossRefGoogle Scholar
  48. Espinoza EO, Mann MJ, Bleasell B (1995) Arsenic and mercury in traditional Chinese herbal balls (letter). N Engl J Med 333:803–804CrossRefGoogle Scholar
  49. Evans PJ, Smith C, Mitchinson MJ, Halliwell B (1995) Metal ion release from mechanically disrupted human arterial wall. Implications for the development of atherosclerosis. Free Radic Res 23:465–469CrossRefGoogle Scholar
  50. Falk H, Caldwell GG, Ishak KG et al (1981) Arsenic-related hepatic angiosarcoma. Am J Ind Med 2:43–50CrossRefGoogle Scholar
  51. Fargion S, Bissoli F, Fracanzani AL et al (1996) No association between genetic hemochromatosis and α-1 antitrypsin deficiency. Hepatology 24:1161–1164Google Scholar
  52. Fraser R, Muller N, Colman N et al (1999a) Pleural effusion. In: Fraser and Pare’s diagnosis of diseases of the chest. W. B. Saunders, PhiladelphiaGoogle Scholar
  53. Fraser R, Muller N, Colman N et al (1999b) Inhalation of inorganic dust (pneumoconiosis). In: Fraser and Pare’s diagnosis of diseases of the chest. W. B. Saunders, PhiladelphiaGoogle Scholar
  54. Frustaci A, Magnavita N, Chimenti C, Caldarulo M, Sabbioni E, Pietra R, Cellini C, Possati GF, Maseri A (1999) Marked elevation of myocardial trace elements in idiopathic dilated cardiomyopathy compared with secondary cardiac dysfunction. J Am Coll Cardiol 33:1578–1583CrossRefGoogle Scholar
  55. Gandhi RK, Robarts FH (1962) Hourglass stricture of the stomach and pyloric stenosis due to ferrous sulphate poisoning. Br J Surg 49:613–617CrossRefGoogle Scholar
  56. Gangaidzo IT, Gordeuk VK (1995) Hepatocellular carcinoma and African iron overload. Gut 37:727–730CrossRefGoogle Scholar
  57. Ganne-Carrié N, Christidis C, Chastang C et al (2000) Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective followup study. Gut 46:277–282CrossRefGoogle Scholar
  58. Ge K, Yang G (1993) The epidemiology of selenium deficiency in the etiological study of endemic diseases in china. Am J Clin Nutr 57:259S–263SGoogle Scholar
  59. Ge K, Xue A, Bai J, Wang S (1983) Keshan disease—an endemic cardiomyopathy in China. Virchows Arch A Pathol Anat Histopathol 401:1–15CrossRefGoogle Scholar
  60. George DK, Goldwurm S, MacDonald GA et al (1998) Increased hepatic iron concentration in non-alcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 114:311–318CrossRefGoogle Scholar
  61. Ghadially FN (1979) Ultrastructural localization and in situ analysis of iron, bismuth, and gold inclusions. CRC Crit Rev Toxicol 6(4):303–350CrossRefGoogle Scholar
  62. Gibbs A (1996) Occupational lung disease. In: Hasleton P (ed) Spencer’s pathology of the lung. McGraw-Hill, New YorkGoogle Scholar
  63. Gokal R, Millard PR, Weatherall DJ et al (1979) Iron metabolism in haemodialysis patients. Q J Med 48:369–391Google Scholar
  64. Good PF et al (1992a) Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer’s disease: a laser microprobe (LAMMA) study. Ann Neurol 31:286–292CrossRefGoogle Scholar
  65. Good PF, Olanow CW, Perl DP (1992b) Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson’s disease: a LAMMA study. Brain Res 593:343–346CrossRefGoogle Scholar
  66. Gordeuk VR, Boyd RD, Brittenham GM (1986) Dietary iron overload in rural Sub-Saharan Africa. Lancet 1:1310–1313CrossRefGoogle Scholar
  67. Gordeuk V, Mukübi SJ, Hasstedt SJ et al (1992) Iron overload in Africa: interaction between a gene and dietary iron content. N Engl J Med 326:95–100CrossRefGoogle Scholar
  68. Greenberg S, Roggli V (1992) Carcinoma of the lung. In: Roggli V, Greenberg S, Pratt P (eds) Pathology of asbestos-associated disease. Little Brown & Company, BostonGoogle Scholar
  69. Hall JC, Harruff R (1989) Fatal cardiac arrhythmia in a patient with interstitial myocarditis related to chronic arsenic poisoning. South Med J 82:1557–1560CrossRefGoogle Scholar
  70. Hanada K, Hashimoto I, Kon A, Kida K, Mita R (1998) Silver in sugar particles and systemic Argyria. Lancet 351:960Google Scholar
  71. Haywood S, Müller T, Müller W et al (2001) Copper-associated liver disease in north ronaldsay sheep: a possible animal model for non-wilsonian hepatic copper toxicosis of infancy and childhood. J Pathol 195:264–269CrossRefGoogle Scholar
  72. Helwig E (1951) Chemical (beryllium) granulomas of the skin. Mil Surg 109:540–558Google Scholar
  73. Hennigar GR, Greene WB, Walker EM et al (1979) Hemochromatosis caused by excessive vitamin iron intake. Am J Pathol 96:611–624Google Scholar
  74. Hezode C, Cazeneuve C, Coué O et al (1999) Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatitis histological lesions. J Hepatol 31:979–984CrossRefGoogle Scholar
  75. Holtzman NA, Elliot DA, Heller RH (1986) Copper intoxication: report of a case with observations on ceruloplasmin. N Engl J Med 275:347–352CrossRefGoogle Scholar
  76. Horslen SP, Tanner MS, Lyon TDB et al (1994) Copper associated childhood cirrhosis. Gut 35:1497–1500CrossRefGoogle Scholar
  77. Hsu CH, Yang SA, Wang JY, Yu HS, Lin SR (1999) Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan. Br J Cancer 80:1080–1086CrossRefGoogle Scholar
  78. Hughes JM, Weill H (1991) Asbestosis as a precursor of asbestos related lung cancer: results of a prospective mortality study. Br J Ind Med 48:229–233Google Scholar
  79. Hume L, Roe M (1992) The biodurability of chrysotile asbestos. Am Mineral 77:1125–1128Google Scholar
  80. Hunter D, Russell DS (1954) Focal cerebral and cerebellar atrophy in a human subject due to organic mercury compounds. J Neurol Neurosurg Psychol 17:235–241CrossRefGoogle Scholar
  81. Hutchinson J (1888) On some examples of arsenic-keratosis of the skin and arsenic-cancer. Trans Pathol Soc Lond 39:352–363Google Scholar
  82. Huttunen JK (1997) Selenium and cardiovascular diseases—an update. Biomed Environ Sci 10:220–226Google Scholar
  83. Iribarren C, Sempos CT, Eckfeldt JH, Folsom AR (1998) Lack of association between ferritin level and measures of LDL oxidation: the ARIC study. Atherosclerosis risk in communities. Atherosclerosis 139:189–195CrossRefGoogle Scholar
  84. James JA (1970) Acute iron poisoning: assessment of severity and prognosis. J Pediatr 77:117–119CrossRefGoogle Scholar
  85. Jensen S, Jernelov A (1969) Biological methylation of mercury in aquatic organisms. Nature 223:753–756CrossRefGoogle Scholar
  86. Jhaveri SS (1959) A case of cirrhosis and primary carcinoma of the liver in chronic arsenical intoxication. Br J Ind Med 16:248–250Google Scholar
  87. Jingbo PI, Hiroshi Y, Yoshito K, Guifan S, Takahiko Y, Hiroyuki A, Claudia HR, Nobuhiro S (2002) Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water. Environ Health Perspect 110(4):331–336CrossRefGoogle Scholar
  88. Johnson RA, Baker SS, Fallon JT, Maynard EP 3rd, Ruskin JN, Wen Z, Ge K, Cohen HJ (1981) An occidental case of cardiomyopathy and selenium deficiency. N Engl J Med 304:1210–1212CrossRefGoogle Scholar
  89. Joshi VV (1987) Indian childhood cirrhosis. Perspect Paediatr Pathol 11:175–192Google Scholar
  90. Kageyama F, Kobayashi Y, Kawasaki T et al (2000) Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C. Am J Gastroenterol 95:1041–1050CrossRefGoogle Scholar
  91. Kardinaal AF, Kok FJ, Kohlmeier L, Martin-Moreno JM, Ringstad J, Gomez-Aracena J, Mazaev VP, Thamm M, Martin BC, Aro A, Kark JD, Delgado-Rodriguez M, Riemersma RA, van’t Veer P, Huttunen JK (1997) Association between toenail selenium and risk of acute myocardial infarction in European men. The EURAMIC study. European antioxidant myocardial infarction and breast cancer. Am J Epidemiol 145:373–379CrossRefGoogle Scholar
  92. Kesteloot H, Roelandt J, Willems J, Class JM, Joosens JV (1968) An inquiry into the role of cobalt in the heart disease of chronic beer drinkers. Circulation 37:854–864CrossRefGoogle Scholar
  93. Kew J, Morris C, Aihie A et al (1993) Arsenic and mercury intoxication due to Indian ethnic remedies. Br Med J 306:506–507CrossRefGoogle Scholar
  94. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F (1997) Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 96:3300–3307CrossRefGoogle Scholar
  95. Kitchin KT (2001) Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol Appl Pharmacol 172(3):249–261CrossRefGoogle Scholar
  96. Koch P, Bahmer FA (1999) Oral lesions and symptoms related to metals used in dental restorations: a clinical, allergological, and histologic study. J Am Acad Dermatol 42:422–430CrossRefGoogle Scholar
  97. Kopp SJ, Barron JT, Tow JP (1988) Cardiovascular actions of lead and relationship to hypertension: a review. Environ Health Perspect 78:91–99CrossRefGoogle Scholar
  98. Krenzelok EP, Hoff JV (1979) Accidental iron poisoning: a problem of marketing and labeling. Pediatrics 63:591–596Google Scholar
  99. Labadie H, Stoessel P, Callard P, Beaugrand M (1990) Hepatic veno-occlusive disease and perisinusoidal fibrosis secondary to arsenic poisoning. Gastroenterology 99:1140–1143Google Scholar
  100. Lansdown A (1995) Physiological and toxicological changes in the skin resulting from the action and interaction of metal ions. Crit Rev Toxicol 25:397–462CrossRefGoogle Scholar
  101. Lefkowitch JH, Honig CL, King ME, Hagstrom JWC (1982) Hepatic copper overload and features of Indian childhood cirrhosis in an American sibship. N Engl J Med 307:271–277CrossRefGoogle Scholar
  102. Li Y, Nan BS (1989) Correlation of selenium, glutathione peroxidase activity and lipoperoxidation rates in dilated cardiomyopathy. Chin Med J 102:670–671Google Scholar
  103. Li JH, Rossman TC (1989) Inhibition of DNA ligase activity by arsenite: a possible mechanism of its comutagenesis. Mol Toxicol 2:1–9Google Scholar
  104. Li GS, Wang F, Kang D, Li C (1985) Keshan disease: an endemic cardiomyopathy in China. Hum Pathol 16:602–609CrossRefGoogle Scholar
  105. Ludwig J, Farr GH, Freese DK, Sternlieb I (1995) Chronic hepatitis and hepatic failure in a 14-year-old girl. Hepatology 22:1874–1879CrossRefGoogle Scholar
  106. Ludwig J, Hashimoto E, Poroyko MD et al (1997) Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology 112:888–890CrossRefGoogle Scholar
  107. Lunchtrath H (1972) Cirrhosis of the liver in chronic arsenical poisoning of vintners. Ger Med Mon 2:127–128Google Scholar
  108. Maggiore G, De Giacomo C, Sessa F, Burgio GR (1987) Idiopathic hepatic copper toxicosis in a child. J Pediatr Gastroenterol Nutr 6:980–983CrossRefGoogle Scholar
  109. Maheswaran R, Morris S, Falconer S, Grossinho A, Perry I, Wakefield J, Elliott P (1999) Magnesium in drinking water supplies and mortality from acute myocardial infarction in north west England. Heart 82:455–460Google Scholar
  110. Mahon NG, Coonar AS, Jeffery S, Coccolo F, Akiyu J, Zal B, Houlston R, Levin GE, Baboonian C, McKenna WJ (2000) Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy. Heart 84:541–547CrossRefGoogle Scholar
  111. Maloney M (1996) Arsenic in dermatology. Dermatol Surg 22:301–304CrossRefGoogle Scholar
  112. Mandishona E, MacPhail AP, Gordeuk VR et al (1998) Dietary iron overload as a risk factor for hepatocellular carcinoma in black Africans. Hepatology 27:1563–1566CrossRefGoogle Scholar
  113. Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer’s disease. Free Radic Biol Med 23:134–147CrossRefGoogle Scholar
  114. Marsh D (1979) Organic mercury: methylmercury compounds. In: Vinken PJ, Bryun GW (eds) Handbook of clinical neurology, vol 36. North-Holland, Amsterdam, pp 73–81Google Scholar
  115. Mazumder DNG, Chakraborty AK, Ghosh A et al (1988) Chronic arsenic toxicity from drinking tube well water in rural West Bengal. Bull WHO 66:499–506Google Scholar
  116. McDonald JC (1980) Asbestos and lung cancer: has the case been proven? Chest 78:374–376Google Scholar
  117. McDonald A, McDonald J (1987) Epidemiology of malignant mesothelioma. In: Antman K, Aisner J (eds) Asbestos-related malignancy. Harcourt Brace Jovanovich, OrlandoGoogle Scholar
  118. Mena I (1979) Manganese poisoning. In: Vinken PJ, Bryun GW (eds) Handbook of clinical neurology, vol 36. North-Holland, Amsterdam, pp 217–237Google Scholar
  119. Mena I et al (1967) Chronic manganese poisoning: clinical picture and manganese turnover. Neurology 17:128–136CrossRefGoogle Scholar
  120. Mendis S (1989) Magnesium, zinc, and manganese in atherosclerosis of the aorta. Biol Trace Elem Res 22:251–256CrossRefGoogle Scholar
  121. Meyers DG (1996) The iron hypothesis—does iron cause atherosclerosis? Clin Cardiol 19:925–929CrossRefGoogle Scholar
  122. Modell CB (1975) Transfusional haemochromatosis. In: Kief H (ed) Iron metabolism and its disorders. Excerpta Medica, Amsterdam, pp 230–239Google Scholar
  123. Monoguerra AS (1976) Iron poisoning: report of a fatal case in an adult. Am J Hosp Pharmacol 33:1088–1090Google Scholar
  124. Morgan A (1980) Effect of length on the clearance of fibers from the lung and on body formation. In: Wagner J (ed) Biologic effects of mineral fibers. International Agency for Research on Cancer, LyonGoogle Scholar
  125. Morgan A, Holmes A (1980) Concentrations and dimensions of coated and uncoated asbestos fibres in the human lung. Br J Ind Med 37:25–32Google Scholar
  126. Morgan A, Holmes A (1985) The enigmatic asbestos body: its formation and significance in asbestos-related disease. Environ Res 38:283–292CrossRefGoogle Scholar
  127. Morgan W, Seaton A (1975) Occupational lung diseases. W. B. Saunders, PhiladelphiaGoogle Scholar
  128. Muehrcke RC, Pirani CL (1968) Arsine-induced anuria: a correlative clinicopathological study with electron microscopic observations. Ann Intern Med 68(4):853–866Google Scholar
  129. Müller T, Feichinger H, Berger H, Muller W (1996) Endemic Tyrolean infantile cirrhosis: an ecogenetic disease disorder. Lancet 347:877–880CrossRefGoogle Scholar
  130. Müller-Höcker J, Meyer U, Wiebecke B, Hübner G (1985) Copper storage disease of the liver and chronic dietary copper intoxication in two further German infants mimicking Indian childhood cirrhosis. Pathol Res Pract 183:39–45CrossRefGoogle Scholar
  131. Müller-Höcker J, Weib M, Meyer U et al (1987) Fatal copper storage disease of the liver in a German infant resembling Indian childhood cirrhosis. Virchows Arch (A) 411:379–385CrossRefGoogle Scholar
  132. Murphy G (1995) Skin. In: Craighead J (ed) Pathology of environmental and occupational disease. Mosby, St. Louis, pp 437–453Google Scholar
  133. Murphy M, Hunt S, McDonald GSA et al (1991) Intrahepatic cholestasis secondary to gold therapy. Eur J Gastroenterol Hepatol 3:855–859Google Scholar
  134. Nakamuro K, Sayato Y (1981) Comparative studies of chromosomal aberration induced by trivalent and pentavalent arsenic. Mutat Res 88:73–80CrossRefGoogle Scholar
  135. Narang R, Ridout D, Nonis C, Kooner JS (1997) Serum calcium, phosphorus and albumin levels in relation to the angiographic severity of coronary artery disease. Int J Cardiol 60:73–79CrossRefGoogle Scholar
  136. Navarro-Alarcon M, Lopez-Garcia de la Serrana H, Perez-Valero V, Lopez-Martinez C (1999) Serum and urine selenium concentrations in patients with cardiovascular diseases and relationship to other nutritional indexes. Ann Nutr Metab 43:30–36CrossRefGoogle Scholar
  137. Needleman HL (1988) The persistent threat of lead: medical and sociological issues. Curr Probl Pediatr 18:697–744Google Scholar
  138. Needleman HL, Gunnoe C, Leviton A (1979) Deficits in psychologic and classroom performance in children with elevated dentine lead levels. N Engl J Med 300:689–695CrossRefGoogle Scholar
  139. Needleman HL, Schell A, Bellinger D (1990) The long-term effects of exposure to low doses of lead in childhood. An 11th year follow-up report. N Engl J Med 322:83–88CrossRefGoogle Scholar
  140. Neve J (1996) Selenium as a risk factor for cardiovascular diseases. J Cardiovasc Risk 3:42–47CrossRefGoogle Scholar
  141. Newland MC et al (1989) Visualizing manganese in the primate basal ganglia with magnetic resonance imaging. Eur Neurol 11106:251–258Google Scholar
  142. Nightingale SL (1997) Action to prevent accidental iron poisonings in children. JAMA 277:1343CrossRefGoogle Scholar
  143. O’Neill NC, Tanner MS (1989) Uptake of copper from brass vessels in bovine milk and its relevance to Indian childhood cirrhosis. J Pediatr Gastroenterol Nutr 9:167–172CrossRefGoogle Scholar
  144. Olanow CW et al (1994) Manganese-induced neurotoxicity. In: Mizuno Y, Calne DB, Horowski R (eds) Advances in research on neurodegeneration. Vol II. Etiopathogenesis. Birkhauser, Boston, pp 53–62CrossRefGoogle Scholar
  145. Olanow CW et al (1996) Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Neurology 46:492–498CrossRefGoogle Scholar
  146. Oliver RAM (1959) Siderosis following transfusions of blood. J Pathol Bacteriol 77:171–194CrossRefGoogle Scholar
  147. Oster O (1993) Trace element concentrations (Cu, Zn, Fe) in sera from patients with dilated cardiomyopathy. Clin Chim Acta 214:209–218CrossRefGoogle Scholar
  148. Oster O, Prellwitz W (1990) Selenium and cardiovascular disease. Biol Trace Elem Res 24:91–103CrossRefGoogle Scholar
  149. Patrizi A, Rizzoli L, Vincenzi C, Trevisi P, Tosti A (1999) Sensitization to thimerosal in atopic children. Contact Dermat 40:94–97CrossRefGoogle Scholar
  150. Perl DP, Brody AR (1980) Alzheimer’s disease: X-ray spectrographic evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science 208:297–299CrossRefGoogle Scholar
  151. Perl DP, Good PF (1992) Aluminum and the neurofibrillary tangle: results of tissue microprobe studies. In: Williams RMP (ed) Ciba symposium: aluminum in biology and medicine. Wiley, New York, pp 217–236Google Scholar
  152. Pestaner JP, Ishak KG, Mullick FG, Centeno J (1999) Ferrous sulfate toxicity: a review of autopsy findings. Biol Trace Elem Res 70:1–8CrossRefGoogle Scholar
  153. Pimental JC, Menezes AP (1977) Liver disease in vineyard sprayers. Gastroenterology 72:275–289Google Scholar
  154. Pirisi M, Scott CA, Avellini C et al (2000) Iron deposition and progression of disease in chronic hepatitis C. Role of interface hepatitis, portal inflammation, and HFE missense mutations. Am J Clin Pathol 113:546–554CrossRefGoogle Scholar
  155. Raines DA, Kinsara AJ, Eid Fawzy M, Vasudevan S, Mohamed GE, Legayada ES, Al-Rawithi S, El-Yazigi A (1999) Plasma and urinary selenium in Saudi Arabian patients with dilated cardiomyopathy. Biol Trace Elem Res 69:59–68CrossRefGoogle Scholar
  156. Ramirez P, Eastmond DA, Laclette JP, Ostrosky-Wegman P (1997) Disruption of microtubule assembly and spindle formation for the induction of aneuploid cells by sodium arsenite and vanadium pentoxide. Mutat Res 386:291–298CrossRefGoogle Scholar
  157. Rauramaa R, Vaisanen S, Mercuri M, Rankinen T, Penttila I, Bond MG (1994) Association of risk factors and body iron status to carotid atherosclerosis in middle-aged eastern Finnish men. Eur Heart J 15:1020–1027Google Scholar
  158. Rayman MP (2000) The importance of selenium to human health. Lancet 356:233–241CrossRefGoogle Scholar
  159. Reusche E, Koch V, Friedrich HJ, Nunninghoff D, Stein P, Rob PM (1996) Correlation of drug-related aluminum intake and dialysis treatment with deposition of argyrophilic aluminum-containing inclusions in CNS and in organ systems of patients with dialysis-associated encephalopathy. Clin Neuropathol 15:342–347Google Scholar
  160. Riggio O, Montagnese F, Fiore P et al (1997) Iron overload in patients with chronic viral hepatitis: how common is it? Am J Gastroenterol 92:1298–1301Google Scholar
  161. Roberts G (1971) The pathology of parietal pleural plaques. J Clin Pathol 24:348–353CrossRefGoogle Scholar
  162. Roggli V (1989) Pathology of human asbestosis: a critical review. In: Fenoglio-Preiser C (ed) Advances in pathology. Year Book Medical Publishers, ChicagoGoogle Scholar
  163. Roggli V (1992) Asbestos bodies and nonasbestos ferruginous bodies. In: Roggli V, Greenberg S, Pratt P (eds) Pathology of asbestos-related disease. Little Brown & Company, BostonGoogle Scholar
  164. Roggli V (1994) The pneumoconioses: asbestosis. In: Saldana M (ed) Pathology of pulmonary disease. J. B. Lippincott, PhiladelphiaGoogle Scholar
  165. Roggli V, Pratt P (1983) Numbers of asbestos bodies on iron-stained sections in relation to asbestos body counts in lung tissue digests. Hum Pathol 14:355–361CrossRefGoogle Scholar
  166. Roggli V, Pratt P (1992) Asbestosis. In: Roggli V, Greenberg S, Pratt P (eds) Pathology of asbestos-associated diseases. Little Brown & Company, BostonGoogle Scholar
  167. Roggli V, Shelburne J (1994) Pneumoconioses, mineral and vegetable. In: Dail D, Hammar S (eds) Pulmonary pathology. Springer, New YorkGoogle Scholar
  168. Rosenberg HG (1974) Systemic arterial disease and chronic arsenicism in infants. Arch Pathol 97:360–365Google Scholar
  169. Rubenowitz E, Axelsson G, Rylander R (1999) Magnesium and calcium in drinking water and death from acute myocardial infarction in women. Epidemiology 10:31–36CrossRefGoogle Scholar
  170. Russell M, Langley M, Truett A, King L, Boyd A (1997) Lichenoid dermatitis after consumption of gold-containing liquor. J Am Acad Dermatol 36:841–844CrossRefGoogle Scholar
  171. Salonen JT, Alfthan G, Huttunen JK, Pikkarainen J, Puska P (1982) Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet 2:175–179CrossRefGoogle Scholar
  172. Salonen JT, Salonen R, Seppanen K, Kantola M, Parviainen M, Alfthan G, Maenpaa PH, Taskinen E, Rauramaa R (1988) Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in eastern Finnish men. Atherosclerosis 70:155–160CrossRefGoogle Scholar
  173. Salonen JT, Seppanen K, Lakka TA, Salonen R, Kaplan GA (2000) Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis 148:265–273CrossRefGoogle Scholar
  174. Salvini S, Hennekens CH, Morris JS, Willett WC, Stampfer MJ (1995) Plasma levels of the antioxidant selenium and risk of myocardial infarction among U.S. Physicians. Am J Cardiol 76:1218–1221CrossRefGoogle Scholar
  175. Sanchez-Fructuoso AI, Torralbo A, Arroyo M, Luque M, Ruilope LM, Santos JL, Cruceyra A, Barrientos A (1996) Occult lead intoxication as a cause of hypertension and renal failure. Nephrol Dial Transplant 11:1775–1780CrossRefGoogle Scholar
  176. Schafer AI, Cheron RG, Dluchy R et al (1981) Clinical consequences of acquired transfusional iron overload in adults. N Engl J Med 304:319–324CrossRefGoogle Scholar
  177. Scheinberg IH, Sternlieb I (1994) Is non-Indian childhood cirrhosis caused by excess dietary copper? Lancet 344:1002–1004CrossRefGoogle Scholar
  178. Schoolmeester WL, White DR (1980) Arsenic poisoning. South Med J 73:198CrossRefGoogle Scholar
  179. Schramel P, Müller-Höcker J, Meyer U et al (1988) Nutritional copper intoxication in three carcinoma infants with severe liver cell damage (features of Indian childhood cirrhosis). J Trace Elem Electrolyte Health Dis 2:85–89Google Scholar
  180. Schumann K (2001) Safety aspects of iron in food. Ann Nutr Metab 45:91–101CrossRefGoogle Scholar
  181. Searle J, Leggett BA, Crawford DHG, Powell LW (2001) Iron storage disease. In: MacSween RNM, Burt AD, Portmann BC, Ishak KG, Scheuer PJ, Anthony PP (eds) Pathology of the liver. Churchill Livingstone, London, pp 257–272Google Scholar
  182. Selikoff IJ, Hammond EC, Seidman H (1980) Latency of asbestos disease among insulation workers in the United States and Canada. Cancer 46:2736–2740CrossRefGoogle Scholar
  183. Sempos CT, Looker AC, Gillum RE, McGee DL, Vuong CV, Johnson CL (2000) Serum ferritin and death from all causes and cardiovascular disease: the NHANES II mortality study. National health and nutrition examination study. Ann Epidemiol 10:441–448CrossRefGoogle Scholar
  184. Shiono Y, Wakusawa S, Hayashi H et al (2001) Iron accumulation in the liver of male patients with Wilson’s disease. Am J Gastroenterol 96:3147–3151CrossRefGoogle Scholar
  185. Shiraki H (1979) Neuropathological aspects of organic mercury intoxication, including Minamata disease. In: Vinken PJ, Bryun GW (eds) Handbook of clinical neurology, vol 36. North-Holland, Amsterdam, pp 83–145Google Scholar
  186. Simeonova PP, Luster MI (2000) Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms. J Environ Pathol Toxicol Oncol 19:281–286Google Scholar
  187. Sluis-Cremer GK, Bezuidenhout BN (1989) Relation between asbestosis and bronchial cancer in amphibole asbestos miners (see comments). Br J Ind Med 46:537–540Google Scholar
  188. Smetana HF, Hadley GG, Sirsat SM (1961) Infantile cirrhosis. An analytic review of the literature and a report of 50 cases. Pediatrics 28:107–127Google Scholar
  189. Sokas RK, Simmens S, Sophar K, Welch LS, Liziewski T (1997) Lead levels in Maryland construction workers. Am J Ind Med 31:188–194CrossRefGoogle Scholar
  190. Spitainy KC, Brondum J, Vogt RL et al (1984) Drinking-water-induced copper intoxication in a Vermont family. Pediatrics 74:1103–1106Google Scholar
  191. Staessen JA, Bulpitt CJ, Fagard R, Lauwerys RR, Roels H, Thijs L, Amery A (1994) Hypertension caused by low-level lead exposure: myth or fact? J Cardiovasc Risk 1:87–97CrossRefGoogle Scholar
  192. Staessen JA, Roels H, Fagard R (1996) Lead exposure and conventional and ambulatory blood pressure: a prospective population study. PheeCad investigators. J Am Med Assoc 275:1563–1570CrossRefGoogle Scholar
  193. Styblo M, Drobna Z, Jaspers I, Lin S, Thomas DJ (2002) The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ Health Perspect 110(5):767–771CrossRefGoogle Scholar
  194. Suadicani P, Hein HO, Gyntelberg F (1992) Serum selenium concentration and risk of ischaemic heart disease in a prospective cohort study of 3000 males. Atherosclerosis 96:33–42CrossRefGoogle Scholar
  195. Tanner MS, Kantarjian AH, Bhave SA, Pandit AN (1983) Early introduction of copper-contaminated animal milk feed as a possible cause of Indian childhood cirrhosis. Lancet 2:992–995CrossRefGoogle Scholar
  196. Tanner MS, Bhave SA, Prodham AM, Pandit AN (1987) Clinical trials of penicillamine in Indian childhood cirrhosis. Arch Dis Child 62:118–1124CrossRefGoogle Scholar
  197. Tchounwou PB, Wilson BA, Schneider J, Ishaque A (2000) Cytogenetic assessment of arsenic trioxide toxicity in the mutatox, Ames II, and CAT-Tox assays. Met Ions Biol Med 6:89–91Google Scholar
  198. Tchounwou PB, Wilson BA, Ishaque A, Schneider J (2001) Atrazine potentiation of arsenic trioxide-induced cytotoxicity and gene expression in human liver carcinoma cells (HepG2). Mol Cell Biochem 222:49–259CrossRefGoogle Scholar
  199. Timbrell V, Pooley F, Wagner J (1970) Characteristics of respirable asbestos fibers. In: Shaprio H (ed) Pneumoconioses: proceedings of the international conference, Johannesburg. Oxford University Press, LondonGoogle Scholar
  200. Tsai S, Wang T, Ko Y (1999) Mortality for certain diseases in areas with high levels of arsenic in drinking water. Arch Environ Health 54:186–193CrossRefGoogle Scholar
  201. Turlin B, Juguet F, Moirand R et al (1995) Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver. Hepatology 22:446–450Google Scholar
  202. Van Glahn WC, Flinn FB, Keim WF (1938) Effect of certain arsenates on the liver. Arch Pathol 25:488–505Google Scholar
  203. Van Heck E, Kint A, Temmerman L (1981) A lichenoid eruption induced by penicillamine. Arch Dermatol 117:676CrossRefGoogle Scholar
  204. Vijaya J, Subramanyam G, Sukhaveni V, Abdul Latheef SA, Gupta SR, Sadhasivaiah G, Salam NM (2000) Selenium levels in dilated cardiomyopathy. J Indian Med Assoc 98:166–169Google Scholar
  205. Virtamo J, Valkeila E, Alfthan G, Punsar S, Huttunen JK, Karvonen MJ (1985) Serum selenium and the risk of coronary heart disease and stroke. Am J Epidemiol 122:276–282Google Scholar
  206. Wagner J, Newhouse M, Corrin B et al (1988) Correlation between fibre content of the lung and disease in east London factory workers. Br J Indust Med 45:305–308Google Scholar
  207. Wei M, Wanibuchi H, Morimura K, Iwai S, Yoshida K, Endo G, Nakae D, Fukushima S (2002) Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. Carcinogenesis 23(8):1387–1397CrossRefGoogle Scholar
  208. Westlin WF (1966) Deferoxamine in the treatment of acute iron poisoning. Clinical experiences with 172 children. Clin Pediatr 5:531CrossRefGoogle Scholar
  209. Wright J, Churg A (1998) Diseases caused by gases and fumes. In: Churg A, Green F (eds) Pathology of occupational lung disease. Williams & Wilkins, BaltimoreGoogle Scholar
  210. Yang FY, Lin ZH, Li SG, Guo BQ, Yin YS (1988) Keshan disease—an endemic mitochondrial cardiomyopathy in China. J Trace Elem Electrolyte Health Dis 2:157–163Google Scholar
  211. Yegin A, Yegin H, Aliciguzel Y, Deger N, Semiz E (1997) Erythrocyte selenium–glutathione peroxidase activity is lower in patients with coronary atherosclerosis. Jpn Heart J 38:793–798CrossRefGoogle Scholar
  212. Yelin G, Taff ML, Sadowski GE (1987) Copper toxicity following massive ingestion of coins. Am J Forensic Med Pathol 8:78–85CrossRefGoogle Scholar
  213. Younossi ZM, Gramlich T, Bacon BR et al (1999) Hepatic iron and nonalcoholic fatty liver disease. Hepatology 30:847–850CrossRefGoogle Scholar
  214. Zenker F (1867) Iron lung: sclerosis pulmonum. Dtsch Arch Klin Med 2:116Google Scholar
  215. Zielhuis R (1977) Public health risks of asbestosis. Pergamon Press, ElmsfordGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • José A. Centeno
    • 1
  • Florabel G. Mullick
    • 2
  • Kamal G. Ishak
  • Teri J. Franks
    • 2
  • Allen P. Burke
    • 2
  • Michael N. Koss
    • 3
  • Daniel P. Perl
    • 4
  • Paul B. Tchounwou
    • 5
  • Joseph P. Pestaner
    • 6
  1. 1.Joint Pathology Center Division of Biophysical ToxicologyMalcolm Grow Medical Clinic Joint Base Andrews Air Naval FacilityWashingtonUSA
  2. 2.The Joint Pathology Center Silver SpringSilver SpringUSA
  3. 3.Medical LaboratoriesUniversity of Southern California Medical CenterLos AngelesUSA
  4. 4.Department of NeurologyUniformed Services University of the Health SciencesBethesdaUSA
  5. 5.College of Science, Engineering and TechnologyJackson State UniversityJacksonUSA
  6. 6.Medical Examiner OfficeWashingtonUSA

Personalised recommendations